Fate Therapeutics, Inc.

Direct answer

Fate Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FATE.

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia...

Can you invest in Fate Therapeutics, Inc.?

Yes. Fate Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FATE.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Fate Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.